Milena Sant

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Int J Cancer 106:416-22. 2003
  2. ncbi EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary
    M Sant
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v61-118. 2003
  3. ncbi Breast carcinoma survival in Europe and the United States
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 100:715-22. 2004
  4. ncbi Should we use incidence, survival or mortality to assess breast cancer trends in European women?
    Milena Sant
    Department of Predictive and Preventive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Nat Clin Pract Oncol 3:228-9. 2006
  5. ncbi Time trends of breast cancer survival in Europe in relation to incidence and mortality
    Milena Sant
    Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 119:2417-22. 2006
  6. ncbi Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan I 20133, Italy
    Eur J Cancer 43:585-92. 2007
  7. ncbi Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Cancer 121:911-4. 2007
  8. ncbi EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:931-91. 2009
  9. ncbi Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Analytical Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Blood 116:3724-34. 2010
  10. ncbi Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Franco Berrino
    Department of Preventive and Predictive Medicine, Fondazione Istituto Nazionale dei Tumori, Milan, Italy
    Lancet Oncol 8:773-83. 2007

Detail Information

Publications36

  1. ncbi Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milan, Italy
    Int J Cancer 106:416-22. 2003
    ..Screening for breast cancer did not seem to affect the survival patterns once stage had been taken into account...
  2. ncbi EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary
    M Sant
    Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v61-118. 2003
    ..The affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes...
  3. ncbi Breast carcinoma survival in Europe and the United States
    Milena Sant
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 100:715-22. 2004
    ..Breast carcinoma survival rates were found to be higher in the U.S. than in Europe...
  4. ncbi Should we use incidence, survival or mortality to assess breast cancer trends in European women?
    Milena Sant
    Department of Predictive and Preventive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Nat Clin Pract Oncol 3:228-9. 2006
  5. ncbi Time trends of breast cancer survival in Europe in relation to incidence and mortality
    Milena Sant
    Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 119:2417-22. 2006
    ..In Estonia, low and stable survival in the context of increasing incidence and mortality suggests inadequate care...
  6. ncbi Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan I 20133, Italy
    Eur J Cancer 43:585-92. 2007
    ..Significantly higher than reference HRs in Estonia and Poland suggest inadequacy or unavailability of treatments...
  7. ncbi Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Etiological Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Int J Cancer 121:911-4. 2007
    ....
  8. ncbi EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:931-91. 2009
    ..For all cancers, 5-year survival conditional to surviving 1-year was higher and varied less with region, than the overall relative survival...
  9. ncbi Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
    Milena Sant
    Department of Preventive and Predictive Medicine, Unit of Analytical Epidemiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Blood 116:3724-34. 2010
    ..Differences in diagnostic and registration criteria are an important cause of incidence variation; however, different distribution of HM risk factors also contributes. The quality of population-based HM data needs further improvement...
  10. ncbi Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study
    Franco Berrino
    Department of Preventive and Predictive Medicine, Fondazione Istituto Nazionale dei Tumori, Milan, Italy
    Lancet Oncol 8:773-83. 2007
    ..This report (EUROCARE-4) presents survival data for eight selected cancer sites and for all cancers combined, diagnosed in adult (aged >/=15 years) Europeans in 1995-99 and followed up until the end of 2003...
  11. ncbi Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups
    Claudia Allemani
    Epidemiology Unit, Department of Preventive and Predictive Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy
    Cancer 107:352-60. 2006
    ..S. To investigate these differences, the authors compared population-based HD survival in relation to morphologic type among populations in Europe and the U.S...
  12. ncbi Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution study
    Claudia Allemani
    Analytical Epidemiology Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 46:1528-36. 2010
    ....
  13. ncbi Do pre-diagnostic drinking habits influence breast cancer survival?
    Claudia Allemani
    Department of Preventive and Predictive Medicine, Analytical Epidemiology Unit, Italy
    Tumori 97:142-8. 2011
    ..The aim of this study was to investigate the survival of women with breast cancer in relation to pre-diagnostic alcohol intake and other factors known to influence prognosis...
  14. ncbi Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States
    Milena Sant
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, I 20133, Milan, Italy
    Eur J Cancer 44:579-87. 2008
    ..Interpretation of marked variation in survival with morphology is complicated by classification inconsistencies. The completeness and standardisation of cancer registry morphology data needs to be improved...
  15. ncbi Contrasts in cancer prevalence in Connecticut, Iowa, and Utah
    Andrea Micheli
    Unita di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer 95:430-9. 2002
    ..In this study, we estimate and analyze the prevalence of seven major cancers in Connecticut, lowa, and Utah using the tried and tested PREVAL method applied to National Cancer Institute registry data...
  16. ncbi Interpreting survival differences and trends
    F Berrino
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 83:9-16. 1997
    ....
  17. ncbi Survival from salivary glands adenoid cystic carcinoma in European populations
    Laura Ciccolallo
    Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, Italy
    Oral Oncol 45:669-74. 2009
    ..Improvements in the disease detection in its early stage and international collaborative research should be encouraged...
  18. ncbi The advantage of women in cancer survival: an analysis of EUROCARE-4 data
    A Micheli
    Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Eur J Cancer 45:1017-27. 2009
    ....
  19. ncbi Life tables for world-wide comparison of relative survival for cancer (CONCORD study)
    Paolo Baili
    Descriptive Epidemiology and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
    Tumori 94:658-68. 2008
    ....
  20. ncbi The ITACARE Study
    M Sant
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 83:17-24. 1997
    ..Overall mortality decreased during the period, more markedly in the north and among women...
  21. ncbi Survival of European children and young adults with cancer diagnosed 1995-2002
    Gemma Gatta
    Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
    Eur J Cancer 45:992-1005. 2009
    ..Cancer survival in patients <25 years is poorly documented in Eastern European countries. Complete cancer registration should be a priority for these countries as an essential part of a policy for effective cancer control in Europe...
  22. ncbi International collaborations in cancer control and the Third International Cancer Control Congress
    Andrea Micheli
    Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Tumori 95:579-96. 2009
    ..As a consequence, less resources of development aids are allocated to control NCDs including cancer...
  23. ncbi European health systems and cancer care
    A Micheli
    Unit of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Ann Oncol 14:v41-60. 2003
    ....
  24. ncbi Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
    G Gatta
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Gut 47:533-8. 2000
    ..Marked differences in population based survival across Europe were found for colorectal cancers diagnosed in 1985-1989...
  25. ncbi Cancer survival increases in Europe, but international differences remain wide
    M Sant
    Department of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy
    Eur J Cancer 37:1659-67. 2001
    ..The persisting regional differences suggest there are corresponding differences in the availability of diagnostic and therapeutic facilities, and in the effectiveness of healthcare systems...
  26. ncbi Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study
    C Allemani
    Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I 20133 Milano, Italy
    Br J Cancer 91:1263-8. 2004
    ..Morphology and hormone receptor status were confirmed as significant survival predictors in this population-based study, even after adjusting for age and stage at diagnosis...
  27. ncbi Differences in stage and therapy for breast cancer across Europe
    M Sant
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 93:894-901. 2001
    ..These wide differences in breast cancer care across Europe in the early 1990s indicate a need for continual monitoring of past treatments to help ensure application of the most effective protocols...
  28. ncbi Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group
    M Sant
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Int J Cancer 77:679-83. 1998
    ..Low survival in the United Kingdom may be due to inadequate adherence to consensus treatment guidelines and greater variation in treatment...
  29. ncbi Survival for retinoblastoma in Europe
    M Sant
    Division of Epidemiology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, I-20133, Milan, Italy
    Eur J Cancer 37:730-5. 2001
    ..There was statistically significant effect related to the period of diagnosis, with a 50% reduction in the relative risk (RR) for children diagnosed in 1986--1989 compared with those diagnosed in 1978-1981...
  30. ncbi Estimated incidence and prevalence of female breast cancer in Italian regions
    A Micheli
    Divisione di Epidemiologia, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Tumori 78:13-21. 1992
    ..In 1987, about 250,000 Italian women had a present or past history of breast cancer: for the 1970-1987 period, prevalence has increased by approximately 5,500 cases per year...
  31. ncbi The prevalence of tumors of the breast and female genital tract in Italy
    M Sant
    Epidemiology Division, National Cancer Institute (INT, Milan, Italy
    Tumori 85:382-6. 1999
    ..The prevalence of corpus uteri cancer decreased slightly in the elderly only, whereas that of cervix uteri cancer decreased at all ages...
  32. ncbi Incident lung cancer survival. Long-term follow-up of a population-based study in Italy
    U Pastorino
    Department of Thoracic Surgery (OCT, National Cancer Institute, Milan, Italy
    Tumori 76:199-204. 1990
    ....
  33. ncbi Breast cancer prevalence measured by the Lombardy Cancer Registry
    A Micheli
    Division of Epidemiology, National Cancer Institute, Milan, Italy
    Tumori 83:875-9. 1997
    ..CONCLUSION: Owing to aging of the population, the improvement in survival and the increasing incidence, the number of prevalent cases will increase. This phenomenon has and will have great importance for the health planning...
  34. ncbi Cancer survival in five continents: a worldwide population-based study (CONCORD)
    Michel P Coleman
    Cancer Research UK Cancer Survival Group, Non communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK
    Lancet Oncol 9:730-56. 2008
    ..This is, to our knowledge, the first worldwide analysis of cancer survival, with standard quality-control procedures and identical analytic methods for all datasets...
  35. ncbi Meningioma
    Christine Marosi
    University of Vienna, Austria
    Crit Rev Oncol Hematol 67:153-71. 2008
    ..Hormonal therapy with progesterone antagonists has shown modest results, while chemotherapy with hydroxyurea appears moderately active...
  36. ncbi Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century
    Riccardo Capocaccia
    National Centre for Epidemiology, Surveillance and Health Promotion, Department of Cancer Epidemiology, Istituto Superiore di Sanita, Rome, Italy
    Am J Gastroenterol 102:1661-70; quiz 1660, 1671. 2007
    ..We compared population-based liver cancer incidence and survival in European and U.S. populations in order to elucidate geographic differences and time trends for these variables...